Tear Fluid Progranulin as a Noninvasive Biomarker for the Monitoring of Corneal Innervation Changes in Patients With Type 2 Diabetes Mellitus.

MLA

Zhou, Tianyi, et al. “Tear Fluid Progranulin as a Noninvasive Biomarker for the Monitoring of Corneal Innervation Changes in Patients With Type 2 Diabetes Mellitus.” Translational Vision Science & Technology, vol. 13, no. 7, July 2024, p. 9. EBSCOhost, https://doi.org/10.1167/tvst.13.7.9.

APA

Zhou, T., Dou, Z., Cai, Y., Zhu, D., & Fu, Y. (2024). Tear Fluid Progranulin as a Noninvasive Biomarker for the Monitoring of Corneal Innervation Changes in Patients With Type 2 Diabetes Mellitus. Translational Vision Science & Technology, 13(7), 9. https://doi.org/10.1167/tvst.13.7.9

Chicago

Zhou, Tianyi, Zhiwei Dou, Yuchen Cai, Dongqing Zhu, and Yao Fu. 2024. “Tear Fluid Progranulin as a Noninvasive Biomarker for the Monitoring of Corneal Innervation Changes in Patients With Type 2 Diabetes Mellitus.” Translational Vision Science & Technology 13 (7): 9. doi:10.1167/tvst.13.7.9.